TX SB269

Requires physicians to report serious adverse events to the federal Vaccine Adverse Event Reporting System (VAERS) for vaccines that are experimental, investigational, or authorized for emergency use by the FDA, if the event occurs within one year of vaccination

Requires physicians to report serious adverse events to the FDA's MedWatch program for drugs that are experimental, investigational, or authorized for emergency use, if the event occurs within one year of administration

Defines "serious adverse event" as death, life-threatening conditions, hospitalization or extended hospitalization, persistent incapacity or substantial disruption of normal life functions, congenital anomalies or birth defects, or conditions requiring medical/surgical intervention to prevent these outcomes

Exempts vaccines and drugs administered as part of clinical trials from the reporting requirements

Establishes enforcement through the Texas Medical Board: initial violations result in non-disciplinary corrective action, while subsequent violations trigger disciplinary action; violations cannot be considered for enforcement purposes after three years but remain in the physician's permanent record

Takes effect September 1, 2025